REVIVA PHARMACEUTCLS HLDGS I
Q2 2026 13F Holders
Symbol
RVPH
CUSIP
76152G209
Type
Equity
Class
COM NEW
Num filings
5
Total reported value, excl. options
$3.67 k
Compare 2026 Q2 to
2026 Q3
2026 Q1
2025 Q4
Manager
Report Date
Value ($000)
Shares
Option Type